Tumorigenesis: The adaptation of mammalian cells to sustained stress environment by epigenetic alterations and succeeding matched mutations

Carcinogenesis

Volumn 26, Issue 8, 2005, Pages 1323-1334

  Karpinets, Tatiana V ^a   Foy, Brent D ^b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CADHERIN; CADHERIN H; CYCLIN D2; DEATH ASSOCIATED PROTEIN KINASE; DNA; DNA POLYMERASE; EPIDERMAL GROWTH FACTOR RECEPTOR; MYC PROTEIN; PROTEIN C FOS; PROTEIN MLH1; PROTEIN P14; PROTEIN P15; PROTEIN P16; PROTEIN P73; RAS PROTEIN; RETINOIC ACID RECEPTOR BETA; SUPPRESSOR OF CYTOKINE SIGNALING 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG; UVOMORULIN;

APOPTOSIS; BIOCHEMISTRY; CANCER GROWTH; CARCINOGENESIS; CELL AGING; CELL DIVISION; CELL MUTANT; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CHROMOSOME ABERRATION; CPG ISLAND; DNA METHYLATION; DNA REPAIR; EPIGENETICS; GENE ACTIVATION; GENOMICS; HUMAN; HYPOTHESIS; MALIGNANT TRANSFORMATION; MAMMAL CELL; MITOSIS; MITOSIS INHIBITION; MOLECULAR DYNAMICS; MUTATIONAL ANALYSIS; NATURAL SELECTION; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; SIGNAL TRANSDUCTION; STRESS; TUMOR SUPPRESSOR GENE; ACCLIMATIZATION; ANIMAL; ENVIRONMENT; GENETICS; GENOME; MAMMAL; MUTATION; NEOPLASM; PATHOLOGY;

ACCLIMATIZATION; ANIMALS; CELL DIVISION; DNA, NEOPLASM; ENVIRONMENT; GENES, TUMOR SUPPRESSOR; GENOME; HUMANS; MAMMALS; MUTATION; NEOPLASMS;

EID: 24944575366     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi079     Document Type: Review

References (139)

1. Sieber,O., Heinimann,K. and Tomlinson,I. (2005) Genomic stability and tumorigenesis. Semin. Cancer Biol., 15, 61-66.
2. Karpinets,T.V. and Foy,B.D. (2004) Model of the developing tumorigenic phenotype in mammalian cells and the role of sustained stress. J. Theor. Biol., 227, 253-264.
3. Feinberg,A.P., Cui,H. and Ohlsson,R. (2002) DNA methylation and genomic imprinting: Insights from cancer into epigenetic mechanisms. Semin. Cancer Biol., 12, 389-398.
4. Dunn,B.K. (2003) Hypomethylation: One side of a larger picture. Ann. N. Y. Acad. Sci., 983, 28-42.
5. Plass,C. and Soloway,P.D. (2002) DNA methylation, imprinting and cancer. Eur. J. Hum. Genet., 10, 6-16.
6. Fruhwald,M.C. and Plass,C. (2002) Global and gene-specific methylation patterns in cancer: Aspects of tumor biology and clinical potential. Mol. Genet. Metab., 75, 1-16.
7. Neumeister,P., Albanese,C., Balent,B., Greally,J. and Pestell,R.G. (2002) Senescence and epigenetic dysregulation in cancer. Int. J. Biochem. Cell. Biol., 34, 1475-1490.
8. Tycko,B. (2003) Genetic and epigenetic mosaicism in cancer precursor tissues. Ann. N. Y. Acad. Sci., 983, 43-54.
9. Bird,A. (2002) DNA methylation patterns and epigenetic memory. Genes Dev., 16, 6-21.
10. Clark,S.J. and Melki,J. (2002) DNA methylation and gene silencing in cancer: Which is the guilty party? Oncogene, 21, 5380-5387.
11. Nephew,K.P. and Huang,T.H. (2003) Epigenetic gene silencing in cancer initiation and progression. Cancer Lett., 190, 125-133.
12. Curradi,M., Izzo,A., Badaracco,G. and Landsberger,N. (2002) Molecular mechanisms of gene silencing mediated by DNA methylation. Mol. Cell. Biol., 22, 3157-3173.
13. Belinsky,S.A., Nikula,K.J., Palmisano,W.A., Michels,R., Saccomanno,G., Gabrielson,E., Baylin,S.B. and Herman,J.G. (1998) Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl Acad. Sci. USA, 95, 11891-11896.
14. Belinsky,S.A., Palmisano,W.A., Gilliland,F.D. et al. (2002) Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res., 62, 2370-2377.
15. Nuovo,G.J., Plaia,T.W., Belinsky,S.A., Baylin,S.B. and Herman,J.G. (1999) In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc. Natl Acad. Sci. USA, 96, 12754-12759.
16. Hardie,L.J., Darnton,S.J., Wallis,Y.L., Chauhan,A., Hainaut,P., Wild,C.P. and Casson,A.G. (2005) p16 expression in Barrett's esophagus and esophageal adenocarcinoma: Association with genetic and epigenetic alterations. Cancer Lett., 217, 221-230.
17. Dominguez,G., Silva,J., Garcia,J.M. et al. (2003) Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors. Mutat. Res., 530, 9-17.
18. Chim,C.S., Wong,A.S. and Kwong,Y.L. (2003) Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias. Ann. Hematol., 82, 738-742.
19. Galm,O., Wilop,S., Reichelt,J., Jost,E., Gehbauer,G., Herman,J.G. and Osieka,R. (2004) DNA methylation changes in multiple myeloma. Leukemia, 18, 1687-1692.
20. Lewis,C.M., Cler,L.R., Bu,D.W., Zochbauer-Muller,S., Milchgrub,S., Naftalis,E.Z., Leitch,A.M., Minna,J.D. and Euhus,D.M. (2005) Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk. Clin. Cancer Res., 11, 166-172.
21. Olopade,O.I. and Wei,M. (2003) FANCF methylation contributes to chemoselectivity in ovarian cancer. Cancer Cell, 3, 417-420.
22. Kang,S.H., Bang,Y.J., Im,Y.H., Yang,H.K., Lee,D.A., Lee,H.Y., Lee,H.S., Kim,N.K. and Kim,S.J. (1999) Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer. Oncogene, 18, 7280-7286.
23. Reddy,J., Shivapurkar,N., Takahashi,T. et al. (2005) Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors. Oncogene, 24, 732-736.
24. Waki,T., Tamura,G., Tsuchiya,T., Sato,K., Nishizuka,S. and Motoyama,T. (2002) Promoter methylation status of E-cadherin, hMLH1 and p16 genes in nonneoplastic gastric epithelia. Am. J. Pathol., 161, 399-403.
25. Ferretti,G., Brichon,P.Y. and Moro-Sibilot,D. (2003) Early detection of lung cancer: Role of biomarkers. Eur. Respir. J. Suppl., 39, 36-44.
26. Dulaimi,E., Hillinck,J., Ibanez de Caceres,I., Al-Saleem,T. and Cairns,P. (2004) Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin. Cancer Res., 10, 6189-6193.
27. Luo,L., Chen,W.D. and Pretlow,T.P. (2005) CpG island methylation in aberrant crypt foci and cancers from the same patients. Int. J. Cancer, 115, 747-751.
28. Wang,P., Wang,X. and Pei,D. (2004) Mint-3 regulates the retrieval of the internalized membrane-type matrix metalloproteinase, MT5-MMP, to the plasma membrane by binding to its carboxyl end motif EWV. J. Biol. Chem., 279, 20461-20470.
29. Krop,I., Player,A., Tablante,A. et al. (2004) Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types. Mol. Cancer Res., 2, 489-494.
30. Catteau,A. and Morris,J.R. (2002) BRCA1 methylation: A significant role in tumour development? Semin. Cancer Biol., 12, 359-371.
31. Yoshida,K. and Miki,Y. (2004) Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription and cell cycle in response to DNA damage. Cancer Sci., 95, 866-871.
32. Kim,H.C., Kim,C.N., Yu,C.S., Roh,S.A. and Kim,J.C. (2003) Methylation of the hMLH1 and hMSH2 promoter in early-onset sporadic colorectal carcinomas with microsatellite instability. Int. J. Colorectal Dis. 18, 196-202.
33. Geisler,J.P., Goodheart,M.J., Sood,A.K., Holmes,R.J., Hatterman-Zogg,M.A. and Buller,R.E. (2003) Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma. Cancer, 98, 2199-2206.
34. Esteller,M. and Herman,J.G. (2004) Generating mutations but providing chemosensitivity: The role of O6-methylguanine DNA methyltransferase in human cancer. Oncogene, 23, 1-8.
35. Fraga,M.F., Herranz,M., Espada,J. et al. (2004) A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors. Cancer Res., 64, 5527-5534.
36. De Craene,B., van Roy,F. and Berx,G. (2005) Unraveling signalling cascades for the Snail family of transcription factors. Cell Signal. 17, 535-547.
37. Suzuki,H., Watkins,D.N., Jair,K.W. et al. (2004) Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat. Genet., 36, 417-422.
38. Jackson,K., Yu,M.C., Arakawa,K., Fiala,E., Youn,B., Fiegl,H., Muller-Holzner,E., Widschwendter,M. and Ehrlich,M. (2004) DNA hypomethylation is prevalent even in low-grade breast cancers. Cancer Biol. Ther., 3 Epub ahead of print.
39. Pogribny,I.P., James,S.J., Jernigan,S. and Pogribna,M. (2004) Genomic hypomethylation is specific for preneoplastic liver in folate/methyl deficient rats and does not occur in non-target tissues. Mutat. Res. 548, 53-59.
40. Cravo,M., Pinto,R., Fidalgo,P., Chaves,P., Gloria,L., Nobre-Leitao,C. and Costa Mira,F. (1996) Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma. Gut, 39, 434-438.
41. Jang,S.J., Soria,J.C., Wang,L., Hassan,K.A., Morice,R.C., Walsh,G.L., Hong,W.K. and Mao,L. (2001) Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Cancer Res., 61 7959-7963.
42. Oshimo,Y., Nakayama,H., Ito,R., Kitadai,Y., Yoshida,K., Chayama,K. and Yasui,W. (2003) Promoter methylation of cyclin D2 gene in gastric carcinoma. Int. J. Oncol., 23, 1663-1670.
43. Fang,J.Y. and Xiao,S.D. (2001) Alteration of DNA methylation in gastrointestinal carcinogenesis. J. Gastroenterol. Hepatol., 16 960-968.
44. Choi,E.K., Uyeno,S., Nishida,N. et al. (1996) Alterations of c-fos gene methylation in the processes of aging and tumorigenesis in human liver. Mutat. Res., 354, 123-128.
45. Aiba,N., Nambu,S., Inoue,K. and Sasaki,H. (1989) Hypomethylation of the c-myc oncogene in liver cirrhosis and chronic hepatitis. Gastroenterol. Jpn., 24, 270-276.
46. Kaneko,Y., Shibuya,M., Nakayama,T., Hayashida,N., Toda,G., Endo,Y., Oka,H. and Oda,T. (1985) Hypomethylation of c-myc and epidermal growth factor receptor genes in human hepatocellular carcinoma and fetal liver. Jpn. J. Cancer Res., 76, 1136-1140.
47. Xu,X.L., Yu,J., Zhang,H.Y., Sun,M.H., Gu,J., Du,X., Shi,D.R., Wang,P., Yang,Z.H. and Zhu,J.D. (2004) Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J. Gastroenterol., 10, 3441-3454.
48. Jones,P.A. and Baylin,S.B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
49. Myohanen,S.K., Baylin,S.B. and Herman,J.G. (1998) Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res., 58, 591-593.
50. Grady,W.M., Wills,J., Guilford,P.J. et al. (2000) Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat. Genet., 26, 16-17.
51. Jones,P.A. and Laird,P.W. (1999) Cancer epigenetics comes of age. Nat. Genet., 21, 163-167.
52. Schulz,W.A., Elo,J.P., Florl,A.R., Pennanen,S., Santourlidis,S., Engers,R., Buchardt,M., Seifert,H.H. and Visakorpi,T. (2002) Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma. Genes Chromosomes Cancer, 35, 58-65.
53. Tsuda,H., Takarabe,T., Kanai,Y., Fukutomi,T. and Hirohashi,S. (2002) Correlation of DNA hypomethylation at pericentromeric heterochromatin regions of chromosomes 16 and 1 with histological features and chromosomal abnormalities of human breast carcinomas. Am. J. Pathol. 161, 859-866.
54. Gaudet,F., Hodgson,J.G., Eden,A., Jackson-Grusby,L., Dausman,J., Gray,J.W., Leonhardt,H. and Jaenisch,R. (2003) Induction of tumors in mice by genomic hypomethylation. Science, 300, 489-492.
55. Wong,N., Lam,W.C., Lai,P.B., Pang,E., Lau,W.Y. and Johnson,P.J. (2001) Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. Am. J. Pathol., 159, 465-471.
56. Szyf,M., Pakneshan,P. and Rabbani,S.A. (2004) DNA methylation and breast cancer. Biochem. Pharmacol., 68, 1187-1197.
57. Narayan,G., Arias-Pulido,H., Nandula,S.V. et al. (2004) Promoter hypermethylation of FANCF: Disruption of Fanconi Anemia-BRCA pathway in cervical cancer. Cancer Res., 64, 2994-2997.
58. Sengupta,S. and Harris,C.C. (2005) p53: Traffic cop at the crossroads of DNA repair and recombination. Nat. Rev. Mol. Cell Biol., 6, 44-55.
59. Toyooka,S., Maruyama,R., Toyooka,K.O. et al. (2003) Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int. J. Cancer 103, 153-160.
60. Lei,Y.X., Joseph,P., Wu,Z.L. and Ong,T.M. (2003) Effect of aberrant DNA methylation on the expression of cancer-related genes in Cd-transformed cells. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, 21, 114-116.
61. Ray,S.S. and Swanson,H.I. (2004) Dioxin-induced immortalization of normal human keratinocytes and silencing of p53 and p16INK4a. J. Biol. Chem., 279, 27187-27193.
62. Counts,J.L. and Goodman,J.I. (1995) Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell, 83, 13-15.
63. Chen,H., Liu,J., Zhao,C.Q., Diwan,B.A., Merrick,B.A. and Waalkes,M.P. (2001) Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. Toxicol. Appl. Pharmacol., 175, 260-268.
64. Tao,L., Yang,S., Xie,M., Kramer,P.M. and Pereira,M.A. (2000) Hypomethylation and overexpression of c-jun and c-myc protooncogenes and increased DNA methyltransferase activity in dichloroacetic and trichloroacetic acid-promoted mouse liver tumors. Cancer Lett., 158, 185-193.
65. Takiguchi,M., Achanzar,W.E., Qu,W., Li,G. and Waalkes,M.P. (2003) Effects of cadmium on DNA-(cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp. Cell Res., 286, 355-365.
66. Sutherland,J.E. and Costa,M. (2003) Epigenetics and the environment. Ann. N. Y. Acad. Sci., 983, 151-160.
67. Conway,K. and Costa,M. (1989) Nonrandom chromosomal alterations in nickel-transformed Chinese hamster embryo cells. Cancer Res., 49, 6032-6038.
68. Kalinich,J.F., Catravas,G.N. and Snyder,S.L. (1989) The effect of gamma radiation on DNA methylation. Radiat. Res., 117, 185-197.
69. Becker,F.F., Holton,P., Ruchirawat,M. and Lapeyre,J.N. (1985) Perturbation of maintenance and de novo DNA methylation in vitro by UVB (280-340 nm)-induced pyrimidine photodimers. Proc. Natl Acad. Sci. USA, 82, 6055-6059.
70. Hagan,C.R., Sheffield,R.F. and Rudin,C.M. (2003) Corrigendum: Human Alu element retrotransposition induced by genotoxic stress. Nat. Genet. 35, 377.
71. Rockwood,L.D., Felix,K. and Janz,S. (2004) Elevated presence of retrotransposons at sites of DNA double strand break repair in mouse models of metabolic oxidative stress and MYC-induced lymphoma. Mutat. Res., 548, 117-125.
72. Anderson,G.R., Stoler,D.L. and Scarcello,L.A. (1989) Retrotransposon-like VL30 elements are efficiently induced in anoxic rat fibroblasts. J. Mol. Biol., 205, 765-769.
73. Brentnall,T.A., Crispin,D.A., Bronner,M.P., Cherian,S.P., Hueffed,M., Rabinovitch,P.S., Rubin,C.E., Haggitt,R.C. and Boland,C.R. (1996) Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res., 56, 1237-1240.
74. Pantoja,C., de Los Rios,L., Matheu,A., Antequera,F. and Serrano,M. (2005) Inactivation of imprinted genes induced by cellular stress and tumorigenesis. Cancer Res., 65, 26-33.
75. Suzuki,M., Toyooka,S., Shivapurkar,N. et al. (2005) Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection. Oncogene, 24, 1302-1308.
76. Narimatsu,T., Tamori,A., Koh,N., Kubo,S., Hirohashi,K., Yano,Y., Arakawa,T., Otani,S. and Nishiguchi,S. (2004) p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection. Intervirology, 47, 26-31.
77. Sakuma,K., Chong,J.M., Sudo,M., Ushiku,T., Inoue,Y., Shibahara,J., Uozaki,H., Nagai,H. and Fukayama,M. (2004) High-density methylation of p14ARF and p16INK4A in Epstein-Barr virus-associated gastric carcinoma. Int. J. Cancer, 112, 273-278.
78. McClintock,B. (1984) The significance of the responses of the genome to challenge. Science, 226, 792-801.
79. Kim,C., Rubin,C.M. and Schmid,C.W. (2001) Genome-wide chromatin remodeling modulates the Alu heat shock response. Gene, 276, 127-133.
80. van de Lagemaat,L.N., Landry,J.R., Mager,D.L. and Medstrand,P. (2003) Transposable elements in mammals promote regulatory variation and diversification of genes with specialized functions. Trends Genet. 19, 530-536.
81. Lander,E.S., Linton,L.M., Birren,B. et al. (2001) Initial sequencing and analysis of the human genome. Nature, 409, 860-921.
82. Lloyd,A.C. (2002) Limits to lifespan. Nat. Cell Biol., 4, 25-27.
83. Ben-Porath,I. and Weinberg,R.A. (2004) When cells get stressed: An integrative view of cellular senescence. J. Clin. Invest., 113 8-13.
84. Bond,J., Jones,C., Haughton,M., DeMicco,C., Kipling,D. and Wynford-Thomas,D. (2004) Direct evidence from siRNA-directed 'knock down' that p16(INK4a) is required for human fibroblast senescence and for limiting ras-induced epithelial cell proliferation. Exp. Cell Res., 292, 151-156.
85. d'Adda di Fagagna,F., Reaper,P.M., Clay-Farrace,L., Fiegler,H., Carr,P., Von Zglinicki,T., Saretzki,G., Carter,N.P. and Jackson S.P. (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194-198.
86. Jacobs,J.J. and de Lange. T. (2004) Significant role for p16INK4a in p53-independent telomere-directed senescence. Curr. Biol., 14 2302-2308.
87. Beausejour,C.M., Krtolica,A., Galimi,F., Narita,M., Lowe,S.W., Yaswen,P. and Campisi,J. (2003) Reversal of human cellular senescence: Roles of the p53 and p16 pathways. EMBO J., 22, 4212-4222.
88. Yuasa,Y. (2002) DNA methylation in cancer and ageing. Mech. Ageing Dev., 123, 1649-1654.
89. Gonzalgo,M.L. and Jones,P.A. (1997) Mutagenic and epigenetic effects of DNA methylation. Mutat. Res., 386, 107-118.
90. Pfeifer,G.P., Tang,M.S. and Denissenko,M.F. (2000) Mutation hotspots and DNA methylation. Curr. Top. Microbiol. Immunol., 249, 1-19.
91. Mancini,D., Singh,S., Ainsworth,P. and Rodenhiser,D. (1997) Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1). Am. J. Hum. Genet., 61, 80-87.
92. Pfeifer,G.P., You,Y.H. and Besaratinia,A. (2005) Mutations induced by ultraviolet light. Mutat Res., 571, 19-31.
93. Zhang,N., Lin,C., Huang,X., Kolbanovskiy,A., Hingerty,B.E., Amin,S., Broyde,S., Geacintov,N.E. and Patel,D.J. (2005) Methylation of cytosine at C5 in a CpG sequence context causes a conformational switch of a benzo[a]pyrene diol epoxide-N2-guanine adduct in DNA from a minor groove alignment to intercalation with base displacement. J. Mol. Biol., 346, 951-965.
94. Goodman,J.E., Hofseth,L.J., Hussain,S.P. and Harris,C.C. (2004) Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. Environ. Mol. Mutagen., 44, 3-9.
95. Zajaczek,S., Jakubowska,A., Gorski,B., Kurzawski,G., Krzystolik,Z. and Lubinski,J. (1999) Frequency and nature of germline Rb-1 gene mutations in a series of patients with sporadic unilateral retinoblastoma. Eur. J. Cancer, 35, 1824-1827.
96. Harbour,J.W. (1998) Overview of RB gene mutations in patients with retinoblastoma. Implications for clinical genetic screening. Ophthalmology, 105, 1442-1447.
97. Yonghao,T., Qian,H., Chuanyuan,L. and Yandell,D.W. (1999) Deletions and point mutations of p16, p15 gene in primary tumors and tumor cell lines. Chin. Med. Sci. J., 14, 200-205.
98. Wiebauer,K. and Jiricny,J. (1989) In vitro correction of G.T mispairs to G.C pairs in nuclear extracts from human cells. Nature 339, 234-236.
99. Stojic,L., Brun,R. and Jiricny,J. (2004) Mismatch repair and DNA damage signalling. DNA Repair (Amst), 3, 1091-1101.
100. Gifford,G. and Brown,R. (2004) Microsatellite instability: Theory and methods. Methods Mol. Med., 97, 237-250.
101. Robertson,K.D. and Jones,P.A. (2000) DNA methylation: Past, present and future directions. Carcinogenesis, 21, 461-467.
102. Tommasi,S., Denissenko,M.F. and Pfeifer,G.P. (1997) Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases. Cancer Res., 57, 4727-4730.
103. Almeida,A., Kokalj-Vokac,N., Lefrancois,D., Viegas-Pequignot,E., Jeanpierre,M., Dutrillaux,B. and Malfoy,B. (1993). Hypomethylation of classical satellite DNA and chromosome instability in lymphoblastoid cell lines. Hum. Genet., 91, 538-546.
104. Ehrlich,M., Hopkins,N.E., Jiang,G. et al. (2003) Satellite DNA hypomethylation in karyotyped Wilms tumors. Cancer Genet. Cytogenet. 141, 97-105.
105. Deininger,P.L. and Batzer,M.A. (2002) Mammalian retroelements. Genome Res., 12, 1455-1465.
106. Goodier,J.L., Ostertag,E.M. and Kazazian,H.H.Jr (2000) Transduction of 3′-flanking sequences is common in L1 retrotransposition. Hum. Mol. Genet., 9, 653-657.
107. Buzdin,A., Ustyugova,S., Gogvadze,E., Vinogradova,T., Lebedev,Y. and Sverdlov,E. (2002) A new family of chimeric retrotranscripts formed by a full copy of U6 small nuclear RNA fused to the 3′ terminus of 11. Genomics, 80, 402-406.
108. Lev-Maor,G., Sorek,R., Shomron,N. and Ast,G. (2003) The birth of an alternatively spliced exon: 3′ splice-site selection in Alu exons. Science, 300, 1288-1291.
109. Schmid,C.W. (1996) Alu: Structure, origin, evolution, significance and function of one-tenth of human DNA. Prog. Nucleic Acid Res. Mol. Biol., 53, 283-319.
110. Rodin,S.N. and Rodin,A.S. (2005) Origins and selection of p53 mutations in lung carcinogenesis. Semin. Cancer Biol., 15, 103-112.
111. Blagosklomiy,M.V. (2002) Oncogenic resistance to growth-limiting conditions. Nat. Rev. Cancer, 2, 221-225.
112. Bridges,B.A. (1994) Starvation-associated mutation in Escherichia coli: A spontaneous lesion hypothesis for 'directed' mutation. Mutat. Res., 307, 149-156.
113. Foster,P.L. (2000) Adaptive mutation: Implications for evolution. Bioessays, 22, 1067-1074.
114. Hendrickson,H., Slechta,E.S., Bergthorsson,U., Andersson,D.I. and Roth,J.R. (2002) Amplification-mutagenesis: Evidence that 'directed' adaptive mutation and general hypermutability result from growth with a selected gene amplification. Proc. Natl Acad. Sci. USA, 99, 2164-2169.
115. Kivisaar,M. (2003) Stationary phase mutagenesis: Mechanisms that accelerate adaptation of microbial populations under environmental stress. Environ. Microbiol., 5, 814-827.
116. Rosenberg,S.M. and Hastings,P.J. (2004) Adaptive point mutation and adaptive amplification pathways in the Escherichia coli lac system: Stress responses producing genetic change. J. Bacteriol., 186, 4838-4843.
117. Wright,B.E. (2004) Stress-directed adaptive mutations and evolution. Mol. Microbiol., 52, 643-650.
118. McKenzie,G.J. and Rosenberg,S.M. (2001) Adaptive mutations, mutator DNA polymerases and genetic change strategies of pathogens. Curr. Opin. Microbiol., 4, 586-594.
119. Rubin,H. (1993) Cellular epigenetics: Effects of passage history on competence of cells for 'spontaneous' transformation. Proc. Natl Acad. Sci. USA, 90, 10715-10719.
120. Martin,S.G. (1996) Normal cells and cancer cells. In Bishop,J.M. and Weinberg,R.A. (eds) Scientific American Molecular Oncology. Scientific American, New York, pp. 13-40.
121. Rhim,J.S. (2000) Development of human cell lines from multiple organs. Ann. N. Y. Acad. Sci., 919, 16-25.
122. Newbold,R.R., Bullock,B.C. and McLachlan,J.A. (1990) Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res., 50, 7677-7681.
123. Sciandrello,G., Caradonna,F., Mauro,M. and Barbata,G. (2004) Arsenic-induced DNA hypomethylation affects chromosomal instability in mammalian cells. Carcinogenesis, 25, 413-417.
124. Zhou,H., Randers-Pehrson,G., Geard,C.R., Brenner,D.J., Hall,E.J. and Hei,T.K. (2003) Interaction between radiation-induced adaptive response and bystander mutagenesis in mammalian cells. Radiat. Res., 160 512-516.
125. Suzuki,K., Ojima,M., Kodama,S. and Watanabe,M. (2003) Radiation-induced DNA damage and delayed induced genomic instability. Oncogene, 22, 6988-6993.
126. Lorimore,S.A., Coates,P.J. and Wright,E.G. (2003) Radiation-induced genomic instability and bystander effects: Inter-related nontargeted effects of exposure to ionizing radiation. Oncogene, 22, 7058-7069.
127. Linet,M.S., Wacholder,S. and Zahm,S.H. (2003) Interpreting epidemiologic research: Lessons from studies of childhood cancer. Pediatrics, 112, 218-232.
128. Moggs,J.G., Tinwell,H., Spurway,T. et al. (2004) Phenotypic anchoring of gene expression changes during estrogen-induced uterine growth. Environ. Health Perspect., 112, 1589-1606.
129. Kushner,P.J., Agard,D.A., Greene,G.L., Scanlan,T.S., Shiau,A.K., Uht,R.M. and Webb,P. (2000) Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol., 74, 311-317.
130. Song,R.X.-D., McPherson,R.A., Adam,L., Bao,Y., Shupnik,M., Kumar,R. and Santen,R.J. (2002) Linkage of rapid estrogen action to MAPK activation by ERα-Shc association and Shc pathway activation. Endocrinology, 16, 116-127.
131. Weber,M.J. and Gioeli,D. (2004) Ras signaling in prostate cancer progression. J. Cell Biochem., 91, 13-25.
132. Gatza,M.L., Chandhasin,C., Ducu,R.I. and Marriott,S.J. (2005) Impact of transforming viruses on cellular mutagenesis, genome stability and cellular transformation. Environ. Mol. Mutagen., 45, 304-325.
133. Coussens,L.M. and Werb,Z. (2002) Inflammation and cancer. Nature, 420, 860-867.
134. Brower,V. (2005) Feeding the flame: New research adds to role of inflammation in cancer development. J. Natl Cancer Inst., 97 251-253.
135. Nguyen,T.H. (2004) Mechanisms of metastasis. Clin. Dermatol., 22, 209-216.
136. Liotta,L.A. and Kohn,E. (2004) Anoikis: Cancer and the homeless cell. Nature, 430, 973-974.
137. So,A., Gleave,M., Hurtado-Col,A. and Nelson,C. (2005) Mechanisms of the development of androgen independence in prostate cancer. World J. Urol., 23, 1-9.
138. Poirier,L.A. (2002) The effects of diet, genetics and chemicals on toxicity and aberrant DNA methylation: An introduction. J. Nutr., 132, 2336-2339.
139. Li,S., Hursting,S.D., Davis,B.J., McLachlan,J.A. and Barrett,J.C. (2003) Environmental exposure, DNA methylation and gene regulation: Lessons from diethylstilbesterol-induced cancers. Ann. N. Y. Acad. Sci., 983, 161-169.